The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study
NCT02390414
·
clinicaltrials.gov ↗
COMPLETED
Status
290
Enrollment
OTHER
Sponsor class
Conditions
Myelodysplastic Syndromes (MDS)
Sponsor
Dana-Farber Cancer Institute